Watch the on-demand session.
Dr. Luz Alonso-Crisostomo and Dr. Charlie Dunlop from AstraZeneca share how genome editing is advancing drug development, from target validation to building more predictive cell models.
Presented at EditCo Draughts & Discoveries 2026 in Cambridge, UK, this session highlights real-world applications, key challenges, and practical insights for translating genome editing into impactful research outcomes.
Interested in applying these approaches to your research?